KELLANOVA (K)
(Delayed Data from NYSE)
$57.68 USD
0.00 (0.00%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $57.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.68 USD
0.00 (0.00%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $57.68 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Zacks News
Kellogg (K) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Kellogg (K) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Kellogg (K) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Kellogg (K) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The J.M. Smucker (SJM) Looks Troubled: Input Costs a Challenge
by Zacks Equity Research
The J.M. Smucker (SJM) is battling commodity cost inflation, together with supply-chain volatility surrounding the availability of labor and transportation.
Medifast's (MED) OPTAVIA System a Key Driver, SG&A Costs High
by Zacks Equity Research
Medifast (MED) has long been gaining on the strength of its OPTAVIA lifestyle solution and coaching support system, while rising SG&A costs are a worry.
Mondelez (MDLZ) Troubled by Elevated Costs, Acquisitions Aid
by Zacks Equity Research
Mondelez (MDLZ) is encountering input cost inflation like many other food companies. However, the company's prudent acquisitions have been boosting the top line.
TreeHouse Foods (THS) Hurt by Cost Inflation, Pricing a Breather
by Zacks Equity Research
TreeHouse Foods (THS) is encountering elevated costs of commodity, freight and packaging. The company's pricing efforts are underway.
Factors to Watch Before Conagra Brands' (CAG) Q1 Earnings
by Zacks Equity Research
Conagra Brands' (CAG) first-quarter fiscal 2022 results are likely to reflect the impact of input cost inflation. The Foodservice business recovery is likely to have acted as an upside.
Things to Note Ahead of PepsiCo's (PEP) Q3 Earnings Results
by Zacks Equity Research
PepsiCo's (PEP) Q3 results are expected to reflect gains from brand investment, resilience in the food category and improving on-premise beverage sales amid supply-chain constraints.
Factors to Watch Ahead of Lamb Weston's (LW) Q1 Earnings Release
by Zacks Equity Research
Lamb Weston's (LW) Q1 results are likely to reflect cost inflation of key production inputs, packaging and transportation, while the away-from-home food demand recovery is likely to have aided.
Factors to Watch Ahead of McCormick's (MKC) Q3 Earnings Release
by Zacks Equity Research
McCormick's (MKC) third-quarter fiscal 2021 results are likely to reflect benefits from acquisitions and foodservice demand recovery, while rising costs are a concerning factor.
Zacks Industry Outlook Highlights: Kellogg, Flowers Foods, Conagra Brands, J. M. Smucker and TreeHouse Foods
by Zacks Equity Research
Zacks Industry Outlook Highlights: Kellogg, Flowers Foods, Conagra Brands, J. M. Smucker and TreeHouse Foods
United Natural (UNFI) Queued for Q4 Earnings: Factors to Watch
by Zacks Equity Research
United Natural's (UNFI) fourth-quarter fiscal 2021 results are likely to reflect e-commerce strength and benefits from buyouts, while higher costs might have been a concern.
Input Cost Inflation Turns Things Sour for These Food Stocks
by Vrishali Bagree
Food companies such as Conagra (CAG), Kellogg (K), The J.M. Smucker (SJM) and TreeHouse Foods (THS) are seeing escalated input costs. Most companies are battling higher ingredients, transportation and packaging costs.
Kellogg (K) Gains on Emerging Market Strength, Costs Flare Up
by Zacks Equity Research
Kellogg (K) is gaining on its solid emerging market performance as well as brand strength. However, the company expects elevated cost inflation in the second half of 2021.
Walmart (WMT) Ups Guidance on Q2 Earnings & Revenue Beat
by Zacks Equity Research
Walmart's (WMT) second-quarter fiscal 2022 results reflect higher earnings and sales, with continued e-commerce strength. Management raises fiscal 2022 view.
Company News for Aug 6, 2021
by Zacks Equity Research
Companies in the news are: REGN, HBI, K, YETI
Kellogg's (K) Q2 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results reflect tough comparisons with the year-ago period, though away-from-home channel recovery and emerging market strength were upsides.
Kellogg (K) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Kellogg (K) delivered earnings and revenue surprises of 10.68% and 4.01%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
K, BYND & 3 Other Food Stocks to Watch for Earnings on August 5
by Vrishali Bagree
While food stocks may show gains from foodservice recovery and solid demand, high costs are a woe for Kellogg (K), Beyond Meat (BYND), Post Holdings (POST), Celsius Holdings (CELH) and Corteva (CTVA).
Monster Beverage (MNST) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Strength in the energy drinks business, innovation and improved e-commerce are expected to have aided Monster Beverage (MNST) in Q2. Higher operating costs are likely to have dented its performance.
TreeHouse Foods (THS) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter results are likely to reflect the impact of lower retail demand owing to tough comparisons with the year-ago period's stock-hoarding trends.
Everything Worth Noting Ahead of Kellogg's (K) Q2 Earnings
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results are likely to reflect escalated costs and moderation in at-home consumption-related demand. That said, the company's brand strength has been a driver.
B&G Foods (BGS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
B&G Foods' (BGS) second-quarter 2021 results are likely to reflect escalated input costs for ingredients, packaging and transportation, though rising online sales have been aiding.
Medifast (MED) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Medifast's (MED) second-quarter 2021 results are likely to reflect continued strength in OPTAVIA lifestyle solution and coaching support system.
Kellogg (K) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Kellogg (K) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.